IL6R and pulmonary embolism: Our investigation focused on assessing the impact of these IL6R variants on the risk of multiple respiratory diseases, including COPD, bronchitis, asthma, pulmonary embolism, idiopathic pulmonary fibrosis, and lung cancer (Table 1).